Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

Autor: Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, Kröger N, Einsele H, Vesole DH, Dimopoulos M, San Miguel J, Avet Loiseau H, Hajek R, Chen WM, Anderson KC, Ludwig H, Sonneveld P, Pavlovsky S, Palumbo A, Richardson PG, Barlogie B, Greipp P, Vescio R, Turesson I, Westin J, Boccadoro M, CAVO, MICHELE
Přispěvatelé: Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, Kröger N, Einsele H, Vesole DH, Dimopoulos M, San Miguel J, Avet-Loiseau H, Hajek R, Chen WM, Anderson KC, Ludwig H, Sonneveld P, Pavlovsky S, Palumbo A, Richardson PG, Barlogie B, Greipp P, Vescio R, Turesson I, Westin J, Boccadoro M, Cavo M, Hematology, Radiology & Nuclear Medicine
Jazyk: angličtina
Rok vydání: 2010
Předmět:
Cancer Research
medicine.medical_specialty
Myeloma protein
health care facilities
manpower
and services

education
Asymptomatic
Monoclonal Gammopathy of Undetermined Significance
Article
03 medical and health sciences
0302 clinical medicine
Risk Factors
immune system diseases
Internal medicine
hemic and lymphatic diseases
medicine
AL amyloidosis
Humans
Risk factor
Multiple myeloma
health care economics and organizations
030304 developmental biology
0303 health sciences
medicine.diagnostic_test
business.industry
Macroglobulinemia
Hematology
medicine.disease
Prognosis
3. Good health
Surgery
Oncology
030220 oncology & carcinogenesis
Serum protein electrophoresis
Practice Guidelines as Topic
Disease Progression
medicine.symptom
business
Multiple Myeloma
Monoclonal gammopathy of undetermined significance
Zdroj: Digital.CSIC. Repositorio Institucional del CSIC
instname
Leukemia, 24(6), 1121-1127. Nature Publishing Group
ISSN: 0887-6924
Popis: International Myeloma Working Group22.-- et al.
Monoclonal gammopathy of undetermined significance (MGUS) was identified in 3.2% of 21 463 residents of Olmsted County, Minnesota, 50 years of age or older. The risk of progression to multiple myeloma, Waldenstrom's macroglobulinemia, AL amyloidosis or a lymphoproliferative disorder is approximately 1% per year. Low-risk MGUS is characterized by having an M protein
Databáze: OpenAIRE